Irene Shui is a post-doctoral research fellow at the Harvard School of Public Health. Her research focuses on the molecular epidemiology of prostate cancer, including investigating the role of genetic variation, gene expression, blood biomarkers, and epigenetic markers in prostate cancer incidence and progression. She is also particularly interested in the role of vitamin D in lethal prostate cancer.